Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-4978
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Research progress of natural compounds in anti-liver fibrosis by affecting autophagy of hepatic stellate cells ; volume:48 ; number:2 ; day:20 ; month:2 ; year:2021 ; pages:1915-1924 ; date:2.2021
Molecular biology reports ; 48, Heft 2 (20.2.2021), 1915-1924, 2.2021
- Urheber
-
Shu, Yongxiang
Liu, Xuyou
Huang, Haifeng
Wen, Qi
Shu, Jianchang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11033-021-06171-w
- URN
-
urn:nbn:de:101:1-2021041621484901274334
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shu, Yongxiang
- Liu, Xuyou
- Huang, Haifeng
- Wen, Qi
- Shu, Jianchang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect
Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect
Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect
Methyl Helicterate Inhibits Hepatic Stellate Cell Activation Through Modulation of Apoptosis and Autophagy
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression